Co-Authors
This is a "connection" page, showing publications co-authored by Jennifer Kuntz and Mark Schmidt.
Connection Strength
0.712
-
Knowledge About Respiratory Syncytial Virus and Acceptance of Infant Monoclonal Antibody for RSV and RSV Vaccination During Pregnancy. Pediatr Infect Dis J. 2025 Feb 01; 44(2S):S162-S166.
Score: 0.245
-
Burden of Medically Attended Diarrhea and Outpatient Clostridioides difficile Infection Among Persons in 2 Large Integrated Healthcare Settings, 2016-2021. Open Forum Infect Dis. 2024 Jan; 11(1):ofad680.
Score: 0.228
-
Epidemiology of Symptomatic Human Metapneumovirus Infection in the CASCADIA Community-Based Cohort - Oregon and Washington, 2022-2024. MMWR Morb Mortal Wkly Rep. 2025 Apr 03; 74(11):188-193.
Score: 0.062
-
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023. Clin Infect Dis. 2025 Mar 14.
Score: 0.062
-
Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States. J Infect Dis. 2025 Jan 08.
Score: 0.061
-
CASCADIA: a prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults using a remote nasal swab collection and web-based survey design. BMJ Open. 2023 Jul 14; 13(7):e071446.
Score: 0.055